SCI Pharmtech Inc
TWSE:4119
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
86.4
100
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
SCI Pharmtech Inc
Current Portion of Long-Term Debt
SCI Pharmtech Inc
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Current Portion of Long-Term Debt
NT$129.1m
|
CAGR 3-Years
328%
|
CAGR 5-Years
134%
|
CAGR 10-Years
N/A
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Current Portion of Long-Term Debt
NT$91.3m
|
CAGR 3-Years
40%
|
CAGR 5-Years
43%
|
CAGR 10-Years
20%
|
Formosa Laboratories Inc
TWSE:4746
|
Current Portion of Long-Term Debt
NT$480.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Current Portion of Long-Term Debt
NT$18.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Current Portion of Long-Term Debt
NT$1.4B
|
CAGR 3-Years
30%
|
CAGR 5-Years
39%
|
CAGR 10-Years
32%
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Current Portion of Long-Term Debt
NT$83.4m
|
CAGR 3-Years
64%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-2%
|
See Also
What is SCI Pharmtech Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
129.1m
TWD
Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Current Portion of Long-Term Debt amounts to 129.1m TWD.
What is SCI Pharmtech Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
134%
Over the last year, the Current Portion of Long-Term Debt growth was 8 402%. The average annual Current Portion of Long-Term Debt growth rates for SCI Pharmtech Inc have been 328% over the past three years , 134% over the past five years .